Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
59.07%
Operating Margin
24.39%
Net Margin
13.06%
Efficiency Metrics
Revenue per Expense Ratio
1.34
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
31.71%
Income Tax Rate
12.98%
EPS
2.5700000000
Balance Sheet Analysis
Current Ratio
0.73
Cash Ratio
0.40
Working Capital
$-1.02B
Debt to Equity
8.32
Debt to Assets
63.71%
Equity Ratio
7.66%
Cash Flow Analysis
Operating Cash Flow Ratio
-6.42%
Free Cash Flow Ratio
-8.27%
CapEx to Revenue
1.85%
Dividends Paid
$1.03B
Stock Buybacks
$1.20B
Total Shareholder Returns
$2.23B
Cash Position Change
-10.70%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 17.21%
Detailed Growth Metrics
Core Performance
Revenue
18.87%
Net Income
209.12%
EPS
195.40%
Operating Income
27.60%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
130.46%
Operating Cash Flow
68.23%
Free Cash Flow
60.98%
Balance Sheet Health
Assets
12.40%
Debt
18.16%
Book Value per Share
25.73%
Inventory
0.00%
Shareholder Returns
Dividends per Share
17.21%
Shares Outstanding
5.14%
Long Term Trends
3Y Revenue/Share
53.45%
5Y Revenue/Share
97.19%
3Y Dividend/Share
63.97%
5Y Dividend/Share
242.60%